ESMO 2025 special: Prof. James presents the BladderPath trial
UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks to Prof. Nicholas James (GB) on the results of the final survival analysis from the BladderPath trial, a randomised comparison of upfront magnetic resonance imaging versus transurethral resection for staging new bladder cancers.
This interview was recorded at ESMO 2025 in Berlin, Germany. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.
For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.
Contact our organiser
Email: educationonline@uroweb.org